StockNews.com initiated coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Tuesday. The brokerage issued a sell rating on the stock. Separately, Dawson James initiated coverage on Tonix Pharmaceuticals in a research report on Wednesday, February 28th. They set a buy rating and a $3.00 price […]